GlassScriptPhysician profile
Charles Anthony Carlton
NPI 1003820572
$4,397.34
in general payments reported to CMS, 2019-2025
42 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $33.41 · 2021: $180 · 2022: $638 · 2023: $765 · 2024: $1,099 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,141.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $699.73 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $449.08 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $436.80 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $366.93 | 2019-2025 | |
| Abbvie INC. | $298.21 | 2021-2024 | Vraylar, Ubrelvy |
| Abbott Laboratories | $217.45 | 2022-2025 | Freestyle Libre, Proclaim |
| Shield Therapeutics INC | $194.89 | 2024 | |
| Janssen Pharmaceuticals, INC | $134.56 | 2019-2024 | Xarelto |
| Eisai INC. | $130.08 | 2024-2025 | |
| Exact Sciences Corporation | $114.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dexcom, INC. | $114.05 | 2022-2025 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $111.47 | 2025 | Inspire |
| Amgen INC. | $107.01 | 2023-2025 | Evenity, Prolia, Otezla |
| Astrazeneca Pharmaceuticals LP | $99.86 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Novartis Pharmaceuticals Corporation | $77.66 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Carlton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.